Brian Abrahams analyst RBC

Currently out of the existing stock ratings of Brian Abrahams, 391 are a HOLD (37.34%), 653 are a BUY (62.37%), 3 are a SELL (0.29%).

Brian Abrahams

Work Performance Price Targets & Ratings Chart

Analyst Brian Abrahams, currently employed at RBC, has had 48.51% of price targets met with an average potential upside of 39.3%, reached in 224 days on average.

Brian Abrahams has documented 2,061 price targets and ratings displayed on 60 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on CRBP, .

Wall Street Analyst Brian Abrahams

Analyst best performing recommendations are on CDTX.
The best stock recommendation documented was for PTCT on 6/18/2018. The price target of $38 was fulfilled within 1 day with a profit of $9.88 (20.63%), with a performance score of 206.35.

Average potential price target upside

ATAI BIIB Biogen CELG Celgene DVAX ENTA ETN GILD Gilead Sciences GLPG Galapagos NV ADR HOOK Hookipa Pharma ICPT INCY yte ITCI KPTI Karyopharm Therapeutics KRTX Karuna Therapeutics MRUS NBIX OVID PLRX PTCT SAGE SRPT Sarepta Therapeutics VRTX Vertex Pharmaceuticals CNST IGMS IGM Biosciences BCRX BioCryst Pharmaceuticals ALDR Alder BioPharmaceuticals MRNS MTCR XENE ETNB PRTA REGN Regeneron Pharmaceuticals NBSE ACHN CRBP EIGR Eiger Biopharmaceuticals ITMN MNMD MRTX PTI Proteostasis Therapeutics AMAM Ambrx Biopharma AXSM Axsome Therapeutics APLT CTNM NMRA ACAD MLTX RARE THTX CDTX GHRS NRIX KYMR Kymera Therapeutics APGE CE CNS IT Gartner SA Seabridge Gold PHVS Pharvaris BV ATYR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Mar-2026

$8

$0.65 (8.84%)

$12

3 months 5 days ago
(12-Aug-2026)

0/2 (0%)

$0.77 (10.65%)

Buy Since 18-Oct-2021

$7.5

$0.15 (2.04%)

$25

3 months 28 days ago
(20-Jul-2026)

0/16 (0%)

$0.31 (4.31%)

Buy Since 16-Jan-2026

$16

4 months ago
(17-Jul-2026)

0/2 (0%)

$12.43 (348.18%)

Buy Since 01-Sep-2021

$7.5

$0.15 (2.04%)

4 months ago
(17-Jul-2026)

0/3 (0%)

$0.28 (3.88%)

Buy Since 20-Jan-2026

$16

4 months ago
(17-Jul-2026)

0/4 (0%)

$11.91 (291.20%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Brian Abrahams most bullish on?

Potential upside of $61.4 has been obtained for VRTX (VERTEX PHARMACEUTICALS)

Which stock is Brian Abrahams most reserved on?

Potential downside of -$42.47 has been obtained for REGN (REGENERON PHARMACEUTICALS)

What Year was the first public recommendation made by Brian Abrahams?

On 2012
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?